BMY-25271
|
|
- CAS号:
- 78441-82-4
- 英文名:
- N-[2-[[[5-[(Dimethylamino)methyl]furan-2-yl]methyl]thio]ethyl]-1,2,5-thiadiazole-3,4-diamine1-oxide
- 英文别名:
- BMY-25271;BMY25271,BMY 25271;N-[2-[[[5-[(Dimethylamino)methyl]furan-2-yl]methyl]thio]ethyl]-1,2,5-thiadiazole-3,4-diamine1-oxide;1,2,5-Thiadiazole-3,4-diamine, N3-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-, 1-oxide
- 中文名:
- BMY-25271
- 中文别名:
- 化合物 T10575
- CBNumber:
- CB52216356
- 分子式:
- C12H19N5O2S2
- 分子量:
- 329.44
- MOL File:
- 78441-82-4.mol
|
|
|
BMY-25271化学性质
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
BMY-25271性质、用途与生产工艺
BMY-25271 是一个组胺 H2 受体 (histamine H2 receptor) 拮抗剂。
BMY-25271 is a histamine H2 receptor antagonist. The dose response curves are parallel and oral ED
50
values derived from probit analysis are 0.093, 0.97 and 6.9 mg/kg for BMY-25271, ranitidine and cimetidine, respectively. BMY-25271, therefore, is about 10 and 74 times more potent than ranitidine and cimetidine, respectively. Pretreatment with the highest dose of BMY-25271 does not significantly affect the absorption of aspirin or the formation of its major metabolite, salicylic acid.
BMY-25271
上下游产品信息
上游原料
下游产品
78441-82-4, BMY-25271 相关搜索:
- 化合物 T10575
- 78441-82-4
- BMY25271,BMY 25271
- 1,2,5-Thiadiazole-3,4-diamine, N3-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-, 1-oxide
- N-[2-[[[5-[(Dimethylamino)methyl]furan-2-yl]methyl]thio]ethyl]-1,2,5-thiadiazole-3,4-diamine1-oxide
- BMY-25271